CDKN1B Gene

2020 ◽  
Author(s):  
Keyword(s):  
2015 ◽  
Author(s):  
Raquel Bueno Barbieri ◽  
Lucas Leite Cunha ◽  
Natassia Elena Bufalo ◽  
Danilo Villagelin ◽  
Ligia Vera Assumpcao ◽  
...  

2014 ◽  
Vol 34 (suppl_1) ◽  
Author(s):  
Thomas S Hatsukami ◽  
Xue-Qiao Zhao ◽  
Daniel Rader ◽  
Daniel S Hippe ◽  
Sony Tuteja-Stevens ◽  
...  

Objective: Studies suggest that a SNP in the promoter region of the C DKN1B gene (-838 C>A; rs36228499), a cell cycle inhibitor, may be associated with decreased vascular SMC proliferation and increased risk of MI. Our objective was to test the hypothesis that the -838A allele is associated with decreased carotid plaque progression. Methods: 214 AIM-HIGH participants underwent annual carotid MRI over 2 years using a standardized protocol. Images were analyzed by Core Lab reviewers blinded to the genotyping results. Plaques with ulceration or hemorrhage were excluded as these local features may contribute excess variability or override genotype. Changes in wall thickness (WT) and lumen, wall, fibrous tissue and total vessel volumes were measured. Associations between number of A alleles and remodeling patterns were tested using linear regression. Results: Of the 214 subjects, 161 had suitable MRI and genotype data available for analysis. There was a significant trend toward less growth (more regression) in mean WT for each A allele (p=0.043) (Figure 1). Other plaque variables were not significantly associated with genotype but directionally showed weak trends toward more expansive remodeling for each C allele. Conclusions: These data suggest that -838 C>A SNP of the C DKN1B gene is significantly associated with carotid mean WT progression among subjects with established vascular disease well treated for LDL-C and blood pressure.


2013 ◽  
Vol 40 (11) ◽  
pp. 6371-6377 ◽  
Author(s):  
Heping Xiang ◽  
He Li ◽  
Weiwei Ge ◽  
Weidong Wu ◽  
Ming Gao ◽  
...  

2011 ◽  
Vol 95 (8) ◽  
pp. 2658-2660.e1 ◽  
Author(s):  
Diego Ojeda ◽  
Besma Lakhal ◽  
Dora Janneth Fonseca ◽  
Rim Braham ◽  
Hanène Landolsi ◽  
...  

Blood ◽  
2008 ◽  
Vol 111 (4) ◽  
pp. 2321-2328 ◽  
Author(s):  
Emilie Le Toriellec ◽  
Gilles Despouy ◽  
Gaëlle Pierron ◽  
Nogaye Gaye ◽  
Marjorie Joiner ◽  
...  

T-cell prolymphocytic leukemia (T-PLL) is consistently associated with inactivation of the ATM gene and chromosomal re-arrangements leading to an overexpression of MTCP1/TCL1 oncoproteins. These alterations are present at the earliest stage of malignant transformation, suggesting that additional events are required for overt malignancy. In this study, we pursued the investigation of the 12p13 deletion, previously shown to occur in approximately half of T-PLLs. We refined the minimal region of deletion by single nucleotide and microsatellite polymorphism allelotyping. We defined a 216-kb region containing the CDKN1B gene that encodes the cyclin-dependent kinase inhibitory protein p27KIP1. Sequencing this gene in 47 T-PLL patient samples revealed a nonsense mutation in one case without 12p13 deletion. The absence of biallelic inactivation of CDKN1B for most patients suggested a haploinsufficiency mechanism for tumor suppression, which was investigated in an animal model of the disease. In a Cdkn1b+/− background, MTCP1 transgenics had consistent and multiple emergences of preleukemic clones not observed in control cohorts. The second Cdkn1b allele was maintained and expressed in these preleukemic clones. Altogether, these data strongly implicate CDKN1B haploinsufficiency in the pathogenesis of T-PLL.


Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 1175-1175
Author(s):  
Vikram R Paralkar ◽  
Cristian Taborda ◽  
Yu Yao ◽  
Rishi Prasad ◽  
Jing Luan ◽  
...  

Abstract Mammalian cells express thousands of lineage-restricted long noncoding RNAs (lncRNAs), although the functions of most are unknown. "Knockout" studies to investigate lncRNA function by gene deletion in cells or whole animals have been informative. However, since most lncRNAs show open chromatin and transcription factor (TF) binding at their promoters as well as elsewhere in their genomic loci, it is essential to distinguish the roles of the RNA transcript from those of potential cis-regulatory elements, both of which are eliminated in deletion studies. We identified a novel mouse lncRNA named Drop27 (Downstream of p27) that is transcribed 4 kb downstream of the Cdkn1b gene encoding the cell-cycle inhibitor p27, which is strongly upregulated during erythroid maturation. Drop27 is conserved between mice and humans, has two exons separated by a 21 kb intron, and produces a 400 bp spliced, polyadenylated RNA that is abundantly transcribed and highly enriched in mouse erythroblasts compared to other tissues. We used the CRISPR/Cas system to delete the entire Drop27 locus in the G1E erythroid cell line. Microarray analysis showed reduced Cdkn1b mRNA in Drop27-deleted cells with very few other changes in the transcriptome. Quantitative PCR verified this finding by demonstrating that heterozygous deletion of Drop27 caused reduced Cdkn1b mRNA by 35%, while homozygous deletion led to a 70% reduction. This effect also occurred at the primary transcript level, demonstrating that deletion of the Drop27 reduced Cdkn1b transcription. To distinguish the effects of loss of the lncRNA transcribed from Drop27 from the potential loss of a cis-acting regulatory module in the Drop27 genomic locus, we used homologous recombination to insert a bovine growth hormone (BGH) polyadenylation (polyA) cassette into the first exon of Drop27, 80 bp downstream of the transcription start site. This caused premature termination of the lncRNA transcript while maintaining all genomic sequences, including potential cis-regulatory elements. Analysis of multiple clones showed that homozygous polyA cassette integration reduced full-length Drop27 transcript levels by more than 99%, although Cdkn1b mRNA levels were unaffected. These findings demonstrate that Drop27 lncRNA is dispensable for Cdkn1b transcription, while its genomic sequences are required, indicating that the Drop27 gene locus contains an erythroid cis-regulatory element (enhancer) for the Cdkn1b gene. Several strong candidates for the proposed enhancer are found in the Drop27 gene. Multiple epigenetic features strongly associated with enhancers map in several distinct locations in the Drop27 locus in erythroid and other hematopoietic cells, including DNase hypersensitivity, p300 binding, and multiple transcription factor sites. A functional role for the Drop27 lncRNA is not identified by this experiment, and it is possible that it arose as a byproduct of enhancer activity. Our findings provide new insight into mechanisms of hematopoietic gene expression and are of more broad relevance to the lncRNA field in general. In particular, we demonstrate that the genomic loci of some lncRNA genes may function as cis elements, irrespective of the transcripts arising from them. Disclosures No relevant conflicts of interest to declare.


2021 ◽  
Vol 53 (04) ◽  
pp. 245-256
Author(s):  
Asha Hesarghatta Shyamasunder ◽  
Rekha Pai ◽  
Hemalatha Ramamoorthy ◽  
Dhananjayan Sakhti ◽  
Marie Therese Manipadam ◽  
...  

AbstractMultiple Endocrine Neoplasia type-1 (MEN1) is an autosomal dominant disorder with a combined occurrence of tumours of parathyroid glands, pancreatic islets, and anterior pituitary. About 90% of these patients carry mutations in the MEN1 gene, though the spectrum is not well defined in India. Forty clinically suspected cases of MEN1 were enrolled prospectively over six years; 32 patients (23 index-cases and nine affected relatives) with≥2 classical endocrine tumours of MEN1 were considered definite, and eight were categorised as ‘MEN1-like’. Details of their clinical presentation, treatment and mutational analysis including MEN1 gene, 3′ and 5′ untranslated regions (UTR) of MEN1, CDKN1B, and CaSR genes were collated. Asymptomatic first-degree relatives were also screened. Among the 32 definite MEN1 patients, all had primary hyperparathyroidism, 22 (68.7%) had gastroentero-pancreatic neuroendocrine tumours, and 21 (66%) had pituitary adenoma. Of the 23 definite index-cases, 13 (56.5%) carried mutations in the MEN1 gene. Five of nine affected first-degree relatives (55.5%), and four of 10 asymptomatic relatives (40%) also had MEN1 mutations. Seven of 10 MEN1 mutation-negative definite index-cases harboured p.V109G polymorphism in the CDKN1B gene. All eight MEN1-like cases were negative for mutations and large deletions in MEN1, mutations in 3′ and 5′ UTR of MEN1, CaSR and CDKN1B genes. The study has helped to clearly document the pattern of mutations among Indian MEN1 patients. However, the absence of MEN1 mutation in ~44% of cases and the presence of p.V109G polymorphism in CDKN1B gene raise the question whether such polymorphisms could independently contribute to pathogenesis.


2018 ◽  
Vol 18 (2) ◽  
pp. 482-493 ◽  
Author(s):  
Carmela De Marco ◽  
Nicola Rinaldo ◽  
Fernanda De Vita ◽  
Floriana Forzati ◽  
Elvira Caira ◽  
...  
Keyword(s):  

2020 ◽  
Vol 09 (01) ◽  
Author(s):  
Lifeng Li ◽  
Xiaohong Chen ◽  
Lanlan Xuan ◽  
Ricardo L Carrau ◽  
Nyall R London Jr

Sign in / Sign up

Export Citation Format

Share Document